AngioDynamics, Inc., headquartered in Latham, New York, specializes in developing, manufacturing, and selling medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company, which employs 815 people and went public in 2004, offers products across oncology, venous therapies, and vascular interventions.
Angiodynamic (ANGO) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Angiodynamic's actual EPS was -$0.06, beating the estimate of -$0.17 per share, resulting in a 64.71% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
